Skip to main content
. 2011 Jan 27;6(1):e14593. doi: 10.1371/journal.pone.0014593

Figure 2. Expression of CXCL1–3, CXCL8 and CXCR1/2 in a panel of normal and NSCLC cancer cell lines.

Figure 2

The panel included A549 (adenocarcinoma), SKMES-1 (squamous cell carcinoma), H460, H647 and H1299 (large cell carcinoma), BEAS-2B (SV40 transformed normal bronchoepithelial) and HBEC cell lines (normal bronchial epithelial cell lines immortalised in the absence of viral oncoproteins). Beta actin is included to validate loading efficiency. (M – DNA size marker, -ve – Negative RT-PCR control).